Business · 23/01/2014Updated: 10/17/2026 · 1 min read
FDA Establishes Public Docket to Improve Quality of Abbreviated New Drug Application Submissions
Summary
The FDA is seeking public input on ways to enhance the quality of abbreviated new drug applications (ANDAs) and associated amendments, with the goal of increasing the availability of low-cost, high-quality generic drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →